ATE533059T1 - Hochempfindliche immuntests und kits zur bestimmung von peptiden und proteinen von biologischem interesse - Google Patents

Hochempfindliche immuntests und kits zur bestimmung von peptiden und proteinen von biologischem interesse

Info

Publication number
ATE533059T1
ATE533059T1 AT07847829T AT07847829T ATE533059T1 AT E533059 T1 ATE533059 T1 AT E533059T1 AT 07847829 T AT07847829 T AT 07847829T AT 07847829 T AT07847829 T AT 07847829T AT E533059 T1 ATE533059 T1 AT E533059T1
Authority
AT
Austria
Prior art keywords
kits
proteins
highly sensitive
biological interest
immune tests
Prior art date
Application number
AT07847829T
Other languages
English (en)
Inventor
Barrio J Manuel Sarasa
Original Assignee
Araclon Biotech Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38544110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE533059(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Araclon Biotech Sl filed Critical Araclon Biotech Sl
Application granted granted Critical
Publication of ATE533059T1 publication Critical patent/ATE533059T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT07847829T 2007-08-02 2007-12-05 Hochempfindliche immuntests und kits zur bestimmung von peptiden und proteinen von biologischem interesse ATE533059T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07380227A EP2020602A1 (de) 2007-08-02 2007-08-02 Hochempfindliche Immuntests und Kits zur Bestimmung biologisch interessanter Peptide und Proteine
PCT/EP2007/063334 WO2009015696A1 (en) 2007-08-02 2007-12-05 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest

Publications (1)

Publication Number Publication Date
ATE533059T1 true ATE533059T1 (de) 2011-11-15

Family

ID=38544110

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07847829T ATE533059T1 (de) 2007-08-02 2007-12-05 Hochempfindliche immuntests und kits zur bestimmung von peptiden und proteinen von biologischem interesse

Country Status (23)

Country Link
US (2) US20090035790A1 (de)
EP (2) EP2020602A1 (de)
JP (1) JP5657382B2 (de)
KR (1) KR101461538B1 (de)
CN (1) CN101861521B (de)
AR (1) AR064186A1 (de)
AT (1) ATE533059T1 (de)
AU (1) AU2007357025B2 (de)
BR (1) BRPI0721871A2 (de)
CA (1) CA2689024C (de)
CL (1) CL2007003513A1 (de)
CY (1) CY1112553T1 (de)
DK (1) DK2183599T3 (de)
ES (1) ES2377151T3 (de)
HR (1) HRP20120020T1 (de)
IL (1) IL202598A (de)
MX (1) MX2009013009A (de)
PL (1) PL2183599T3 (de)
PT (1) PT2183599E (de)
RS (1) RS52124B (de)
RU (1) RU2461837C2 (de)
SI (1) SI2183599T1 (de)
WO (1) WO2009015696A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201405802UA (en) * 2009-09-18 2014-11-27 Probiodrug Ag Novel assay for the detection of amyloid beta peptides
DK2510359T3 (en) * 2009-12-11 2015-12-07 Araclón Biotech S L METHODS AND REAGENTS FOR IMPROVED DETECTION OF AMYLOID-BETA PEPTIDES
CN102192985A (zh) * 2010-03-18 2011-09-21 上海依科赛生物制品有限公司 一种人体β淀粉样蛋白试剂盒
KR101352670B1 (ko) * 2010-06-15 2014-01-17 울산대학교 산학협력단 알츠하이머 전구단백질 분비 펩타이드의 축적물을 포함하는 뇌 노화 감별 진단 마커
US20120141985A1 (en) * 2010-07-26 2012-06-07 Snu R&Db Foundation Real-time monitoring of depletion of high-abundance blood proteins or recovery of low-abundance blood proteins by uv spectrometry
WO2012054333A2 (en) * 2010-10-20 2012-04-26 Merck Sharp & Dohme Corp. Methods for identifying inhibitors of abeta42 oligomers
EP2511296A1 (de) * 2011-04-12 2012-10-17 Araclón Biotech, S. L. Antikörper, Kit und Verfahren zur Bestimmung von Amyloidpeptiden
CN103827671B (zh) * 2011-05-03 2017-05-03 联邦科学与工业研究组织 用于检测神经疾病的方法
JP6231263B2 (ja) * 2012-07-17 2017-11-15 株式会社島津製作所 アフィニティ支持体及びそれを用いた物質の捕捉方法
WO2019167830A1 (ja) * 2018-02-27 2019-09-06 株式会社 島津製作所 ＡＰＰ６６９－ｘのＮ末端を特異的に認識する抗体、及び免疫測定法
CN113884683A (zh) * 2020-07-30 2022-01-04 山东京济生物工程有限公司 一种快速检测Aβ42的双抗体夹心ELISA试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811310A (en) * 1986-09-30 1998-09-22 Albert Einstein College Of Medicine Of Yeshiva Univ. The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
AU7121191A (en) * 1990-02-26 1991-10-10 Albert Einstein College Of Medicine Of Yeshiva University Diagnostic assay for alzheimer's disease
US7427392B1 (en) * 1994-11-14 2008-09-23 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
US7964192B1 (en) * 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
ATE312349T1 (de) * 1998-07-03 2005-12-15 Innogenetics Nv Differentielle diagnose von neurodegeneration
AU2001269127A1 (en) * 2000-07-06 2002-01-14 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A novel app mutation associated with an unusual alzheimer's disease pathology
EP1371986A1 (de) * 2002-06-06 2003-12-17 ABETA GmbH Diagnose von Alzheimer basiert auf dem hAbeta42:hAbeta40 Verhältnis
PE20050627A1 (es) * 2003-05-30 2005-08-10 Wyeth Corp Anticuerpos humanizados que reconocen el peptido beta amiloideo
MX2007013825A (es) * 2005-05-05 2008-01-18 Merck & Co Inc Composiciones de un conjugado peptidico y metodos para la prevencion y tratamiento de la enfermedad de alzheimer.

Also Published As

Publication number Publication date
SI2183599T1 (sl) 2012-03-30
MX2009013009A (es) 2010-03-29
US20190178899A1 (en) 2019-06-13
EP2183599B1 (de) 2011-11-09
JP2010535328A (ja) 2010-11-18
IL202598A (en) 2015-10-29
RU2009143671A (ru) 2011-05-27
AR064186A1 (es) 2009-03-18
PT2183599E (pt) 2012-02-13
AU2007357025A1 (en) 2009-02-05
KR101461538B1 (ko) 2014-11-14
AU2007357025B2 (en) 2014-10-23
IL202598A0 (en) 2010-06-30
EP2020602A1 (de) 2009-02-04
KR20100046168A (ko) 2010-05-06
PL2183599T3 (pl) 2012-04-30
CA2689024A1 (en) 2009-02-05
CY1112553T1 (el) 2016-02-10
CA2689024C (en) 2015-02-24
BRPI0721871A2 (pt) 2014-02-18
CL2007003513A1 (es) 2009-02-06
JP5657382B2 (ja) 2015-01-21
CN101861521A (zh) 2010-10-13
RU2461837C2 (ru) 2012-09-20
HRP20120020T1 (hr) 2012-03-31
DK2183599T3 (da) 2012-02-27
RS52124B (en) 2012-08-31
WO2009015696A1 (en) 2009-02-05
ES2377151T3 (es) 2012-03-22
EP2183599A1 (de) 2010-05-12
US20090035790A1 (en) 2009-02-05
CN101861521B (zh) 2014-03-12

Similar Documents

Publication Publication Date Title
ATE533059T1 (de) Hochempfindliche immuntests und kits zur bestimmung von peptiden und proteinen von biologischem interesse
DE602005012555D1 (de) Künstliches protein zur absoluten quantifizierung von proteinen und verwendungen davon
DK1844074T3 (da) Humane antistoffer og proteiner
CU23869B1 (es) Anticuerpos anti-esclerostina y proteínas funcionales
DE112005002192A5 (de) Kraftauswertevorrichtung und Kraftauswerteverfahren zur Bestimmung von Gleichgewichtskenngrössen
DE602006018816D1 (de) Gerät und Methode zur Messung von Eingeweidenfett
DK1904627T3 (da) Fremgangsmåde til fremstilling af prrs-virus og proteiner og diagnostiske testkits til detektion deraf
BRPI0907363A2 (pt) Métodos e composições relativos a peptídeos e proteínas com elementos de c-terminal
EP1789788A4 (de) Immobilisierte proben und verfahren zur detektion von konformativ veränderten prion-proteinen
AT504436B8 (de) Verfahren und vorrichtung zur bestimmung des alkoholgehaltes von flüssigkeiten
DE602004003842D1 (de) Verfahren und automatisiertes Microfluidsystem zum Nachweis von Proteinen in biologischen Proben
BRPI0907864A2 (pt) Identificação de proteínas de ligação específicas para antígenos ou ligandos
EP2061884A4 (de) Sensorproteine und testverfahren dafür
EP1915176A4 (de) Hochsensitive immunassays und antikörper zum nachweis von blutfaktor viii
EP1769244A4 (de) Nachweis oder messung von antigenprotein-antikörpern in biologischen geweben oder proben
BRPI0918233B8 (pt) métodos de triagem para a lesão pulmonar aguda e doença do enxerto contra hospedeiro relacionada à transfusão ou transplante, kits e uso de polipeptídeos
DE602006019849D1 (de) Proteinspaltungsverfahren und verwendung davon
DK2547694T5 (da) Hidtil ukendt signalpeptid og anvendelse deraf til fremstilling af rekombinante proteiner
HK1148026A1 (en) Novel rubella e1 envelope protein variants and their use in the detection of antirubella antibodies e1
PL376121A1 (pl) Zestaw diagnostyczny do badania surowic zwierząt na obecność przeciwciał RHD oraz zestaw diagnostyczny do wykrywania wirusa RHD
DE112005000698A5 (de) Messvorrichtung und Messverfahren zur Bestimmung von Batteriezellenspannungen
BRPI0912676A2 (pt) métodos de análise de material e de inspeção ultra-sônica de um objeto
DE602006002457D1 (de) Bio-disk und Vorrichtung zur Bestimmung und Beobachtung von Zellen
DE602005014715D1 (de) Methode zur Messung von Haut Anisotropie
DE112005002199A5 (de) Verfahren und System zur Echtheitsbestimmung der individual-typischen Merkmale von Prüfobjekten